Transcranial Magnetic Stimulator Market Expected To Reach $2.2 Billion By 2030 As Growth Accelerates At 9.8% CAGR
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The transcranial magnetic stimulator market has been evolving rapidly, driven by increasing demand for innovative neurological treatments and growing awareness of non-pharmacological therapies. This sector is set to continue expanding as new applications and technologies emerge, offering promising solutions for various neurological and psychiatric conditions. Below is a detailed overview of the market’s size, growth factors, key players, trends, and regional insights shaping its future.
Current Market Size and Expected Growth Trajectory of the Transcranial Magnetic Stimulator Market
The transcranial magnetic stimulator market has witnessed notable expansion in recent years. It is projected to grow from $1.39 billion in 2025 to $1.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.5%. This previous growth period was driven by factors such as the rising incidence of depression and neurological disorders, increased awareness about non-drug therapies, the availability of FDA-cleared TMS systems, the growth of mental health clinics, and broader acceptance of neuromodulation treatments. Looking ahead, the market is expected to reach $2.21 billion by 2030, growing at a CAGR of 9.8%. This anticipated rise is fueled by the expanded use of TMS for a wider range of neurological conditions, greater demand for tailored mental health therapies, the growth of outpatient psychiatric services, integration of digital monitoring technologies, and increased investment in neuromodulation research. Key trends include the growing use of non-invasive brain stimulation, expanded applications of repetitive TMS (rTMS) for depression, development of deep TMS (dTMS) clinical uses, a stronger focus on personalized neurostimulation protocols, and the growth of outpatient mental health care.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10525&type=smp
Increasing Prevalence of Neurological Disorders as a Market Growth Driver
One of the main forces propelling the transcranial magnetic stimulator market is the rising prevalence of neurological diseases worldwide. TMS has demonstrated effective results in managing a range of neurological and psychiatric disorders. It serves as a novel approach to treating conditions such as stroke, spasticity, migraines, dementia, and movement disorders. For example, a December 2022 study by the Parkinson’s Foundation, a US nonprofit organization, reported that the number of people living with Parkinson’s disease (PD) is expected to rise from 930,000 in 2020 to 1.2 million by 2030. This growing patient population highlights the increasing need for effective treatment options, which is expected to support the expansion of the transcranial magnetic stimulator market.
Rising Acceptance of TMS Technologies and Expanding Clinical Applications
Another factor contributing to market growth is the broader acceptance and adoption of TMS devices across various neurological and psychiatric fields. As more healthcare providers recognize the benefits of non-pharmacological interventions, the demand for advanced TMS systems continues to rise. The expansion of outpatient psychiatric clinics and integration of digital treatment monitoring further enhance access to and effectiveness of these therapies, thereby driving market growth.
Access The Complete Transcranial Magnetic Stimulator Market Report:
Comprehensive Segmentation of the Transcranial Magnetic Stimulator Market
This market is divided into several key segments to better understand its dynamics:
1) By Type: including Deep Transcranial Magnetic Stimulation (dTMS) Systems, Repetitive Transcranial Magnetic Stimulation (rTMS) Systems, and Theta Burst Stimulation (TBS) Systems.
2) By Treatment Protocol: categorized into High-Frequency TMS, Low-Frequency TMS, Intermittent Theta Burst Stimulation (iTBS), and Continuous Theta Burst Stimulation (cTBS).
3) By Application: covering Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD), Obsessive-Compulsive Disorder (OCD), Parkinson’s Disease, Alzheimer’s Disease and Other Dementias, Epilepsy, and other medical uses.
Subcategories include FDA-Approved dTMS systems and coil-based deep stimulation devices for the dTMS segment; standard and navigated rTMS systems under rTMS; and standalone TBS systems as well as TBS-enabled rTMS platforms for the TBS category.
Innovations and Technological Advances Steering the Transcranial Magnetic Stimulator Market
Leading companies in this space are focusing on innovative technologies such as neuronavigational-guided TMS systems to improve treatment precision and efficiency. These systems utilize image-based guidance by integrating patient-specific neuroimaging with real-time coil tracking, ensuring accurate and reproducible stimulation during procedures. For instance, in March 2023, MagVenture Inc., a US medical device manufacturer, launched the MagVenture TMS Atlas Neuro Navigation System. This advanced platform enhances coil positioning with a user-friendly, high-precision workflow that saves time and increases reliability. It eliminates line-of-sight issues and offers patients a visual representation of their MRI scans alongside real-time coil tracking, fostering greater patient engagement during treatment.
Key Players Influencing the Competitive Landscape of the Transcranial Magnetic Stimulator Market
Several prominent companies dominate the transcranial magnetic stimulator industry, driving innovation and market growth. These include BrainsWay Ltd., Nexstim Plc., The Magstim Company Limited, Neuronetics Inc., MagVenture Inc., MAG & More GmbH, neurocare group AG, Neurosoft, Neuroelectrics, NeuroConn GmbH, Neurofield Inc., Axilum Robotics, Yiruide Neurotech, Brainbox Ltd., Remed Inc., Soterix Medical Inc., Sinovation Medical Technology Co. Ltd., Shenzhen Yingchi Technology Co. Ltd., Wuhan Greentek Bioengineering Co. Ltd., and Vishee Medical Technology Co. Ltd.
Geographical Overview and Regional Market Leadership in Transcranial Magnetic Stimulators
North America held the largest market share in the transcranial magnetic stimulator market in 2025. Meanwhile, the Asia-Pacific region is anticipated to be the fastest-growing area throughout the forecast period. The market report covers other significant regions including Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a broad understanding of global market trends and growth opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
